ALOX12 and prostate carcinoma: The concentration of 12-LOX in platelet-rich plasma in patients with prostate cancer is significantly lower than in patients with BPH; thus, the low concentration of 12-LOX might indicate the increased risk of developing prostate cancer or the onset of the disease in periodically monitored patients.